(Q42638322)

4 November 2017

title

Pneumococcal conjugated vaccine: PHiD-CV. (English)

1 reference

4 November 2017

Ener Cagri Dinleyici

1

1 reference

4 November 2017

Zeynel Abidin Yargic

series ordinal

2

1 reference

4 November 2017

publication date

1 November 2009

1 reference

Expert Review of Anti-infective Therapy

4 November 2017

published in

1 reference

4 November 2017

volume

7

1 reference

4 November 2017

issue

9

1 reference

4 November 2017

page(s)

1063-1074

1 reference

Pneumococcal vaccination in developing countries.

4 November 2017

cites work

1 reference

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.

21 January 2018

1 reference

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

The potential indirect effect of conjugate pneumococcal vaccines

21 January 2018

1 reference

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines

21 January 2018

1 reference

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine

21 January 2018

1 reference

Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera

21 January 2018

1 reference

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

21 January 2018

1 reference

The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity

21 January 2018

1 reference

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

21 January 2018

1 reference

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

21 January 2018

1 reference

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

21 January 2018

1 reference

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines

21 January 2018

1 reference

27th Annual Meeting of the European Society for Pediatric Infectious Disease

21 January 2018

1 reference

Discordance between Staphylococcus aureus nasal colonization and skin infections in children

21 January 2018

1 reference

Epidemiological differences among pneumococcal serotypes

21 January 2018

1 reference

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome

21 January 2018

1 reference

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics

21 January 2018

1 reference

Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso

21 January 2018

1 reference

Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population

21 January 2018

1 reference

Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

21 January 2018

1 reference

Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006.

21 January 2018

1 reference

Invasive pneumococcal infections among hospitalized children in Bamako, Mali

21 January 2018

1 reference

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era.

21 January 2018

1 reference

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease

21 January 2018

1 reference

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema

21 January 2018

1 reference

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population

21 January 2018

1 reference

Streptococcus pneumoniae serotype 19A in children, South Korea

21 January 2018

1 reference

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.09.84

1 reference

4 November 2017

1 reference